Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Mease, Philip J; Ogdie, Alexis; Chakravarty, Soumya D; Shiff, Natalie J; Lin, Iris; McLean, Robert R; Malley, Wendi; Spitzer, Rebecca L; Kavanaugh, Arthur; Merola, Joseph F

Mease, Philip J; Ogdie, Alexis; Chakravarty, Soumya D; Shiff, Natalie J; Lin, Iris; McLean, Robert R; Malley, Wendi; Spitzer, Rebecca L; Kavanaugh, Arthur; Merola, Joseph F.

Afiliação

Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, 601 Broadway, Suite 600, Seattle, WA, 98122, USA. pmease@philipmease.com.
Ogdie A; University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Chakravarty SD; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
Shiff NJ; Drexel University College of Medicine, Philadelphia, PA, USA.
Lin I; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
McLean RR; Adjunct, Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Malley W; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
Spitzer RL; CorEvitas, LLC, Waltham, MA, USA.
Kavanaugh A; CorEvitas, LLC, Waltham, MA, USA.
Merola JF; CorEvitas, LLC, Waltham, MA, USA.

Drugs Real World Outcomes ; 9(4): 617-628, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36243860

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Drugs Real World Outcomes Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google